Your browser doesn't support javascript.
The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients.
Treon, Steven P; Castillo, Jorge J; Skarbnik, Alan P; Soumerai, Jacob D; Ghobrial, Irene M; Guerrera, Maria Luisa; Meid, Kirsten; Yang, Guang.
  • Treon SP; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA.
  • Castillo JJ; Department of Medicine, Harvard Medical School, Boston, MA.
  • Skarbnik AP; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA.
  • Soumerai JD; Department of Medicine, Harvard Medical School, Boston, MA.
  • Ghobrial IM; Lymphoproliferative Disorders Program, Novant Health, Charlotte, NC; and.
  • Guerrera ML; Department of Medicine, Harvard Medical School, Boston, MA.
  • Meid K; Massachusetts General Hospital, Boston, MA.
  • Yang G; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA.
Blood ; 135(21): 1912-1915, 2020 05 21.
Article in English | MEDLINE | ID: covidwho-72434
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Pyrazoles / Pyrimidines / Waldenstrom Macroglobulinemia / Coronavirus Infections / Protein Kinase Inhibitors / Lung Injury / Betacoronavirus Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Blood Year: 2020 Document Type: Article Affiliation country: Blood.2020006288

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Pyrazoles / Pyrimidines / Waldenstrom Macroglobulinemia / Coronavirus Infections / Protein Kinase Inhibitors / Lung Injury / Betacoronavirus Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Blood Year: 2020 Document Type: Article Affiliation country: Blood.2020006288